Advisory committee recommends FDA approve first RSV vaccines for older AmericansÂ
A Food and Drug Administration advisory committee this week recommended the agency approve the first two vaccines to prevent lower respiratory tract disease caused by respiratory syncytial virus in Americans aged 60 and older. In separate Feb. 28 and March 1, a majority of committee members said available data support the safety and effectiveness of the two vaccine candidates, made by Pfizer and GSK. The FDA will now consider whether to approve the vaccines for use in this age group.
Related News Articles
Headline
Shelley Hart, R.N., clinical nurse specialist at Froedtert Menomonee Falls Hospital, explores the hospital's inspiring journey toward delivering exceptional…
Headline
Older adults may be in circumstances that exacerbate challenges to accessing behavioral health care and have complex needs that can complicate behavioral…
Headline
In this conversation, Dave Eaker, geriatric program manager at Atrium Health, and Shannon Morton, assistant vice president of patient care services at Atrium…
Headline
The Centers for Medicare & Medicaid Services July 8 announced over 400 participants in a new model focused on improving dementia care. The Guiding an…
Headline
As Americans age, health care is seeing a shift in addressing the unique needs of older adults, but what about those caring for their loved ones? Diane Mariani…
Headline
Behavioral health conditions among older populations are often underrecognized, undertreated and stigmatized, according to the World Health Organization. Learn…